Kairos Biotech is a biotech start-up that began operating in July 2021 primarily to address improving pre-transplant diagnosis, post-transplant monitoring and in partnership with suitable clinical groups, to provide unique and specific immunosupression. 

We are collaborating with health care providers and biotech service industry to provide the proof of concept for both diagnostics and immunotherapy.

We are a collaborative company looking to partner with both commercial and research organisations to improve diagnostics and remove immunological barriers to transplant or transfusion.  We would welcome interest from additional investors and partners that are interested in diagnostics or clinical immunotherapy and would like to join us on this journey.